Purpose: The aerial parts of Dracocephalum moldavica L. (DM) have been widely used as traditional herbal medicine for cardiovascular diseases and skin problems in Central Asia and Europe. This study evaluated the photoprotective effects of three different DM seed (DMS) extracts against ultraviolet B (UVB)-induced photoaging in human dermal fibroblasts (HDFs) and human keratinocytes (HaCaT cells). Methods: DMS extracts were prepared using supercritical fluid (SC-oil), ethanol (EE), and aqueous (AE) methods. Their ability to regulate the extracellular matrix (ECM) components, including procollagen type I (PC1), matrix metalloproteinase-1 (MMP-1), and elastase-1, which are key biomarkers of photoaging, was evaluated. Results: All extracts restored procollagen synthesis, reduced MMP-1 and elastase-1 production and activity, and upregulated PC1 mRNA expression while downregulating the MMP-1 and elastase-1 mRNA levels in UVB-irradiated cells. SC-oil (0.0001%) and AE (0.125 mg/mL) reversed the PC1 mRNA levels most effectively in HDFs and HaCaT cells, respectively.In addition, SC-oil had the strongest suppressive effect on MMP-1 secretion in HDFs, while EE and AE were more effective in HaCaT cells. The elastase-1 activity and mRNA levels in both cell types were comparable to those treated with L-ascorbic acid, a positive control. Conclusion These findings suggest that DMS extracts, rich in bioactive compounds such as polyphenols, phytosterols, and omega-3 polyunsaturated fatty acids, have significant potential as natural anti-aging agents. By protecting collagen and elastin integrity and modulating ECM biomarkers, DMS extracts may effectively prevent UVB-induced photoaging and improve skin resiliency.

Purpose: The aerial parts of Dracocephalum moldavica L. (DM) have been widely used as traditional herbal medicine for cardiovascular diseases and skin problems in Central Asia and Europe. This study evaluated the photoprotective effects of three different DM seed (DMS) extracts against ultraviolet B (UVB)-induced photoaging in human dermal fibroblasts (HDFs) and human keratinocytes (HaCaT cells). Methods: DMS extracts were prepared using supercritical fluid (SC-oil), ethanol (EE), and aqueous (AE) methods. Their ability to regulate the extracellular matrix (ECM) components, including procollagen type I (PC1), matrix metalloproteinase-1 (MMP-1), and elastase-1, which are key biomarkers of photoaging, was evaluated. Results: All extracts restored procollagen synthesis, reduced MMP-1 and elastase-1 production and activity, and upregulated PC1 mRNA expression while downregulating the MMP-1 and elastase-1 mRNA levels in UVB-irradiated cells. SC-oil (0.0001%) and AE (0.125 mg/mL) reversed the PC1 mRNA levels most effectively in HDFs and HaCaT cells, respectively.In addition, SC-oil had the strongest suppressive effect on MMP-1 secretion in HDFs, while EE and AE were more effective in HaCaT cells. The elastase-1 activity and mRNA levels in both cell types were comparable to those treated with L-ascorbic acid, a positive control. Conclusion These findings suggest that DMS extracts, rich in bioactive compounds such as polyphenols, phytosterols, and omega-3 polyunsaturated fatty acids, have significant potential as natural anti-aging agents. By protecting collagen and elastin integrity and modulating ECM biomarkers, DMS extracts may effectively prevent UVB-induced photoaging and improve skin resiliency.

Purpose: The aerial parts of Dracocephalum moldavica L. (DM) have been widely used as traditional herbal medicine for cardiovascular diseases and skin problems in Central Asia and Europe. This study evaluated the photoprotective effects of three different DM seed (DMS) extracts against ultraviolet B (UVB)-induced photoaging in human dermal fibroblasts (HDFs) and human keratinocytes (HaCaT cells). Methods: DMS extracts were prepared using supercritical fluid (SC-oil), ethanol (EE), and aqueous (AE) methods. Their ability to regulate the extracellular matrix (ECM) components, including procollagen type I (PC1), matrix metalloproteinase-1 (MMP-1), and elastase-1, which are key biomarkers of photoaging, was evaluated. Results: All extracts restored procollagen synthesis, reduced MMP-1 and elastase-1 production and activity, and upregulated PC1 mRNA expression while downregulating the MMP-1 and elastase-1 mRNA levels in UVB-irradiated cells. SC-oil (0.0001%) and AE (0.125 mg/mL) reversed the PC1 mRNA levels most effectively in HDFs and HaCaT cells, respectively.In addition, SC-oil had the strongest suppressive effect on MMP-1 secretion in HDFs, while EE and AE were more effective in HaCaT cells. The elastase-1 activity and mRNA levels in both cell types were comparable to those treated with L-ascorbic acid, a positive control. Conclusion These findings suggest that DMS extracts, rich in bioactive compounds such as polyphenols, phytosterols, and omega-3 polyunsaturated fatty acids, have significant potential as natural anti-aging agents. By protecting collagen and elastin integrity and modulating ECM biomarkers, DMS extracts may effectively prevent UVB-induced photoaging and improve skin resiliency.

Background: Oral cancer drugs, particularly tyrosine kinase inhibitors (TKIs), are increasingly popular due to their convenience.However, they pose challenges like drug interactions, especially with medications like azole antifungals. While the FDA providessome guidance, more detailed information is needed to manage these interactions effectively. A meta-analysis was conducted tounderstand the impact of interactions between TKIs and azole antifungals on adverse events during clinical studies. Methods: A meta-analysis followed PRISMA guidelines. Data from PubMed, EMBASE, and references were searched until November 30, 2021. Inclusion criteria encompassed studies on TKI-antifungal interactions in English. Study selection and quality assessment were conducted by two independent investigators. Results: Out of 158 articles, 11 were selected for analysis. Combination therapy showed a slight increase in adverse events but was not statistically significant (OR 1.02, 95% CI 0.49-2.13, p=0.95). AUC and Cmax fold changes did not significantly impact adverse event development. Both itraconazole and ketoconazole showed no significant difference in adverse event development compared to TKI alone. Conclusions Study finds TKI-DDI not significantlylinked to AE increase; azole antifungal types not related to AE. Future DDI research crucial for drug development.

Background: Oral cancer drugs, particularly tyrosine kinase inhibitors (TKIs), are increasingly popular due to their convenience.However, they pose challenges like drug interactions, especially with medications like azole antifungals. While the FDA providessome guidance, more detailed information is needed to manage these interactions effectively. A meta-analysis was conducted tounderstand the impact of interactions between TKIs and azole antifungals on adverse events during clinical studies. Methods: A meta-analysis followed PRISMA guidelines. Data from PubMed, EMBASE, and references were searched until November 30, 2021. Inclusion criteria encompassed studies on TKI-antifungal interactions in English. Study selection and quality assessment were conducted by two independent investigators. Results: Out of 158 articles, 11 were selected for analysis. Combination therapy showed a slight increase in adverse events but was not statistically significant (OR 1.02, 95% CI 0.49-2.13, p=0.95). AUC and Cmax fold changes did not significantly impact adverse event development. Both itraconazole and ketoconazole showed no significant difference in adverse event development compared to TKI alone. Conclusions Study finds TKI-DDI not significantlylinked to AE increase; azole antifungal types not related to AE. Future DDI research crucial for drug development.

Background: Oral cancer drugs, particularly tyrosine kinase inhibitors (TKIs), are increasingly popular due to their convenience.However, they pose challenges like drug interactions, especially with medications like azole antifungals. While the FDA providessome guidance, more detailed information is needed to manage these interactions effectively. A meta-analysis was conducted tounderstand the impact of interactions between TKIs and azole antifungals on adverse events during clinical studies. Methods: A meta-analysis followed PRISMA guidelines. Data from PubMed, EMBASE, and references were searched until November 30, 2021. Inclusion criteria encompassed studies on TKI-antifungal interactions in English. Study selection and quality assessment were conducted by two independent investigators. Results: Out of 158 articles, 11 were selected for analysis. Combination therapy showed a slight increase in adverse events but was not statistically significant (OR 1.02, 95% CI 0.49-2.13, p=0.95). AUC and Cmax fold changes did not significantly impact adverse event development. Both itraconazole and ketoconazole showed no significant difference in adverse event development compared to TKI alone. Conclusions Study finds TKI-DDI not significantlylinked to AE increase; azole antifungal types not related to AE. Future DDI research crucial for drug development.

Background: Oral cancer drugs, particularly tyrosine kinase inhibitors (TKIs), are increasingly popular due to their convenience.However, they pose challenges like drug interactions, especially with medications like azole antifungals. While the FDA providessome guidance, more detailed information is needed to manage these interactions effectively. A meta-analysis was conducted tounderstand the impact of interactions between TKIs and azole antifungals on adverse events during clinical studies. Methods: A meta-analysis followed PRISMA guidelines. Data from PubMed, EMBASE, and references were searched until November 30, 2021. Inclusion criteria encompassed studies on TKI-antifungal interactions in English. Study selection and quality assessment were conducted by two independent investigators. Results: Out of 158 articles, 11 were selected for analysis. Combination therapy showed a slight increase in adverse events but was not statistically significant (OR 1.02, 95% CI 0.49-2.13, p=0.95). AUC and Cmax fold changes did not significantly impact adverse event development. Both itraconazole and ketoconazole showed no significant difference in adverse event development compared to TKI alone. Conclusions Study finds TKI-DDI not significantlylinked to AE increase; azole antifungal types not related to AE. Future DDI research crucial for drug development.

BACKGROUND/OBJECTIVES: This study analyzed the quality of lunches provided in senior leisure service (SLS) facilities and compared institutional foodservice (IF) and noninstitutional foodservice (non-IF). SUBJECTS/METHODS: Data of 390 adults aged 65 years or older who ate lunches in SLS facilities were analyzed using the information from the 2013–2017 Korea National Health and Nutrition Examination Survey. The participants were classified into IF (n = 129) and non-IF (n = 261) groups according to meal type provided. The intake of major food groups, energy and nutrients, and nutrient adequacy ratio (NAR) and mean adequacy ratio (MAR) were analyzed. The diversity of meals was evaluated by food group patterns, dietary diversity score (DDS) and dietary variety score (DVS). Energy intake was adjusted in model 1, while energy and sex were adjusted in model 2. All confounding variables were adjusted in model 3. RESULTS: The intake of seafoods (P < 0.001 in models 1, 2, and 3), seaweeds (P < 0.01 in models 1 and 2), and dairy products (P < 0.05 in models 1, 2, and 3) was significantly higher in the IF group. No significant difference existed in energy intake; however, the intake of all nutrients except carbohydrate and vitamin C was significantly higher in the IF group. NAR of all nutrients, excluding vitamin C, was higher in the IF group, and MAR was also higher in the IF group (P < 0.001 in models 1, 2, and 3). The IF group had significantly higher DDS and DVS than the non-IF group (P < 0.001). CONCLUSIONS The lunches provided in SLS facilities were better in terms of quantity and quality when provided through IF than through non-IF. More systematic foodservice programs should be implemented in SLS facilities, especially in facilities wherein users prepare their own meals.

BACKGROUND/OBJECTIVES: This study analyzed the quality of lunches provided in senior leisure service (SLS) facilities and compared institutional foodservice (IF) and noninstitutional foodservice (non-IF). SUBJECTS/METHODS: Data of 390 adults aged 65 years or older who ate lunches in SLS facilities were analyzed using the information from the 2013–2017 Korea National Health and Nutrition Examination Survey. The participants were classified into IF (n = 129) and non-IF (n = 261) groups according to meal type provided. The intake of major food groups, energy and nutrients, and nutrient adequacy ratio (NAR) and mean adequacy ratio (MAR) were analyzed. The diversity of meals was evaluated by food group patterns, dietary diversity score (DDS) and dietary variety score (DVS). Energy intake was adjusted in model 1, while energy and sex were adjusted in model 2. All confounding variables were adjusted in model 3. RESULTS: The intake of seafoods (P < 0.001 in models 1, 2, and 3), seaweeds (P < 0.01 in models 1 and 2), and dairy products (P < 0.05 in models 1, 2, and 3) was significantly higher in the IF group. No significant difference existed in energy intake; however, the intake of all nutrients except carbohydrate and vitamin C was significantly higher in the IF group. NAR of all nutrients, excluding vitamin C, was higher in the IF group, and MAR was also higher in the IF group (P < 0.001 in models 1, 2, and 3). The IF group had significantly higher DDS and DVS than the non-IF group (P < 0.001). CONCLUSIONS The lunches provided in SLS facilities were better in terms of quantity and quality when provided through IF than through non-IF. More systematic foodservice programs should be implemented in SLS facilities, especially in facilities wherein users prepare their own meals.

BACKGROUND/OBJECTIVES: A pivotal role of oxidative stress has been emphasized in the pathogenesis as well as in the disease progression of Parkinson's disease (PD). We aimed at investigating serum levels of antioxidant vitamins and elucidating whether they could be associated with the pathogenesis and progression of PD. MATERIALS/METHODS: Serum levels of retinol, α- and γ-tocopherols, α- and β-carotenes, lutein, lycopene, zeaxanthin and β-cryptoxanthin were measured and compared between 104 patients with idiopathic PD and 52 healthy controls matched for age and gender. In order to examine the relationship between antioxidant vitamins and the disease progression, multiple group comparisons were performed among the early PD (Hoehn and Yahr stage I and II, N = 47), advanced PD (stage III and IV, N = 57) and control groups. Separate correlation analyses were performed between the measured antioxidant vitamins and clinical variables, such as Hoehn and Yahr stage and Unified Parkinson's Disease Rating Scale (UPDRS) motor score. RESULTS: Compared to controls, PD patients had lower levels of α- and β-carotenes and lycopene. α-carotene, β-carotene and lycopene levels were significantly reduced in advanced PD patients relative to early PD patients and were negatively correlated with Hoehn and Yahr stage and UPDRS motor score in PD patients. No significant differences were found in serum levels of retinol, α- and γ-tocopherols, and other carotenoids between PD patients and controls. No significant correlations were found between these vitamin levels and clinical variables in PD patients. CONCLUSIONS: We found that serum levels of some carotenoids, α-carotene, β-carotene and lycopene, were lower in PD patients, and that these carotenoids inversely correlated with clinical variables representing disease progression. Our findings suggest that decreases in serum α-carotene, β-carotene and lycopene may be associated with the pathogenesis as well as progression of PD.
Carotenoids ; Disease Progression ; Humans ; Lutein ; Oxidative Stress ; Parkinson Disease* ; Tocopherols* ; Vitamin A* ; Vitamins ; Zeaxanthins